CellRapeutics™ Leukopak from COPD Donor (XS-0426-XU233)

Name: CellRapeutics™ Leukopak from COPD Donor
SKU: XS-0426-XU233
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Derived from donors diagnosed with Chronic Obstructive Pulmonary Disease (COPD), this Leukopak features a leucocyte repertoire shaped by chronic airway obstruction and systemic oxidative stress. The collection is characterized by an increased frequency of activated neutrophils and proinflammatory Th1/Th17 effector cells. It provides a robust primary cell source for researchers analyzing the systemic inflammatory component of pulmonary emphysema and the mechanisms of steroid resistance in chronic respiratory conditions.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from COPD Donor

Cat. No.
XS-0426-XU233

Donor Age
Senior

Donor Health
Leukocytes reflect chronic systemic inflammatory stress and oxidative damage signatures, with an immune cell distribution that correlates with chronic obstructive pulmonary remodeling.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, enhanced to mitigate the effects of systemic hypoxia on cellular ATP levels and maintain monocyte phagocytic function.

Additional Donor Information
Each lot features a Leukopak from donors diagnosed with Chronic Obstructive Pulmonary Disease. Profiles include smoking history, GOLD stage, and recent exacerbation frequency, facilitating studies on chronic inflammatory cell signaling in pulmonary disease.

Clinical Profile
GOLD staging, history of exacerbations, and documented smoking history or environmental exposures.

Additional Information

Medication History
Available upon request. Records of bronchodilators, inhaled/systemic corticosteroids, and chronic medications for cardiovascular comorbidities.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from COPD Donor, Leukopak, COPD

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from COPD Donor (XS-0426-XU233). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.